mugur...I have followed Avanir since 1999 and have purchased stocks and options (puts & calls) and I guaranteed it will go back down and maybe even lower than your $3 to around $2.50.
The FDA still hasn't said "bo!" yet. Avanir shareholders know from Abreva and Neurodex how important the FDA is. Until Avanir submits to them for approval, the stock will rock back and forth. It'll be to traders advantage to watch the swings.
G' day Mate,
Aussie
Australia is a beautiful place with wonderful people that just love Americans. You've got to go there some day. Give it a go Mate.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.